KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Assets (2020 - 2026)

AbCellera Biologics filings provide 7 years of Other Non-Current Assets readings, the most recent being $69.1 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 12.3% to $69.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $69.1 million through Mar 2026, up 12.3% year-over-year, with the annual reading at $51.9 million for FY2025, 90.29% up from the prior year.
  • Other Non-Current Assets hit $69.1 million in Q1 2026 for AbCellera Biologics, up from $51.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $134.2 million in Q3 2024 and bottomed at $1.8 million in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $55.3 million, with a median of $51.9 million recorded in 2025.
  • The largest annual shift saw Other Non-Current Assets plummeted 88.56% in 2022 before it skyrocketed 1270.61% in 2023.
  • AbCellera Biologics' Other Non-Current Assets stood at $46.3 million in 2022, then soared by 103.41% to $94.2 million in 2023, then plummeted by 71.03% to $27.3 million in 2024, then surged by 90.29% to $51.9 million in 2025, then soared by 33.09% to $69.1 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Other Non-Current Assets are $69.1 million (Q1 2026), $51.9 million (Q4 2025), and $53.1 million (Q3 2025).